PRESS RELEASE published on 03/17/2026 at 19:00, 4 months 26 days ago Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2025
BRIEF published on 12/16/2025 at 09:58, 7 months 27 days ago Virbac acquiert Thyronorm pour le traitement de l'hyperthyroïdie féline Acquisition Santé Animale VIRBAC Hyperthyroïdie Féline Thyronorm
BRIEF published on 12/16/2025 at 09:58, 7 months 27 days ago Virbac Acquires Thyronorm to Combat Feline Hyperthyroidism Veterinary Medicine Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
BRIEF published on 12/16/2025 at 09:58, 7 months 27 days ago Virbac acquiert Thyronorm pour lutter contre l'hyperthyroïdie féline Santé Animale Médecine Vétérinaire VIRBAC Hyperthyroïdie Féline Thyronorm
BRIEF published on 12/16/2025 at 09:58, 7 months 27 days ago Virbac acquires Thyronorm for the treatment of feline hyperthyroidism Acquisition Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
PRESS RELEASE published on 12/16/2025 at 09:53, 7 months 27 days ago VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Virbac acquires innovative drug Thyronorm from Norbrook to stabilize feline hyperthyroidism, expanding distribution in key markets and enhancing senior cats' quality of life Acquisition Feline Hyperthyroidism VIRBAC Thyronorm Senior Cats
PRESS RELEASE published on 12/16/2025 at 09:53, 7 months 27 days ago VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm Virbac acquiert Thyronorm pour traiter l'hyperthyroïdie féline, améliorant la qualité de vie des chats âgés. L'acquisition renforce le portefeuille produits de Virbac Acquisition VIRBAC Hyperthyroïdie Féline Thyronorm Chats Âgés
BRIEF published on 11/07/2025 at 15:44, 9 months 5 days ago Virbac: Update on shares and voting rights Euronext Paris Voting Rights Actions Transparency VIRBAC
BRIEF published on 11/07/2025 at 15:44, 9 months 5 days ago Virbac : Mise à jour sur les actions et droits de vote Euronext Paris Droits De Vote Actions Transparence VIRBAC
PRESS RELEASE published on 11/07/2025 at 15:39, 9 months 5 days ago Virbac : Déclaration d'actions et de droits de vote 10/2025 Déclaration du nombre total d’actions et de droits de vote pour VIRBAC sur Euronext Paris. Total brut de droits de vote : 12 704 809, total net : 12 691 973 Euronext Paris Droits De Vote Santé Animale VIRBAC Total Actions
Published on 08/12/2026 at 15:42, 5 hours 46 minutes ago Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 5 hours 46 minutes ago Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 6 hours 28 minutes ago Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 6 hours 43 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 21:05, 22 minutes ago Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 1 hour 30 minutes ago EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 1 hour 50 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/11/2026 at 17:45, 1 day 3 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 3 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 3 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 3 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026